Abstract
A 40-year-old African American woman presented with type B insulin resistance (TBIR) secondary to systemic lupus erythematosus (SLE). The patient's SLE manifestations included pancytopenia, discoid and malar rashes, Raynaud phenomenon, arthralgias, hypocomplementemia, positive antinuclear antibody (ANA), anti-Sm and anti-Sm/RNP antibodies, thyroid autoantibodies, and elevated inflammatory markers.
